Kazuki Sekitani
Directeur/Membre du Conseil chez EPS HOLDINGS, INC.
Postes actifs de Kazuki Sekitani
Sociétés | Poste | Début | Fin |
---|---|---|---|
EPS HOLDINGS, INC. | Directeur/Membre du Conseil | 01/04/2011 | - |
Responsable des Ressources Humaines | 21/12/2018 | - | |
Public Communications Contact | 21/12/2018 | - | |
Corporate Officer/Principal | 01/04/2011 | 21/12/2018 | |
GNI GROUP LTD. | Directeur/Membre du Conseil | 30/03/2023 | - |
Independent Dir/Board Member | 30/03/2023 | - |
Historique de carrière de Kazuki Sekitani
Anciens postes connus de Kazuki Sekitani
Sociétés | Poste | Début | Fin |
---|---|---|---|
KAKEN PHARMACEUTICAL CO., LTD. | Directeur/Membre du Conseil | 01/06/2013 | - |
EPS Global Research, Inc.
EPS Global Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of EPS Holdings, Inc., EPS Global Research, Inc. operates clinical trials. | Directeur/Membre du Conseil | 01/06/2012 | - |
Formation de Kazuki Sekitani
University of Tokyo | Undergraduate Degree |
Statistiques
Internationale
Japon | 5 |
Etats-Unis | 2 |
Opérationnelle
Director/Board Member | 4 |
Human Resources Officer | 1 |
Public Communications Contact | 1 |
Sectorielle
Health Technology | 4 |
Commercial Services | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
KAKEN PHARMACEUTICAL CO., LTD. | Health Technology |
GNI GROUP LTD. | Health Technology |
Entreprise privées | 2 |
---|---|
EPS Holdings, Inc.
EPS Holdings, Inc. BiotechnologyHealth Technology EPS Holdings, Inc. engages in the drug development business. It operates through the following segments: Contract Research Organization (CRO), Site Management Organization (SMO), Contract Sales Organization (CSO), Global Research, Ekishin, and Others. The CRO segment offers clinical trials, data management, and statistical analysis. The SMO segment enters into contracts with medical institutions to conduct clinical trials. The CSO segment provides drug information and awareness for medical and pharmaceutical industries. The Global Research segment provides consignment services through its subsidiary for multilateral clinical trials in Asia-Pacific. The Ekishin segment focuses on medical equipment, pharmaceutical and investment related businesses through its Japan and China based subsidiaries. The Others segment provides various services related to management of clinical research from business processing outsource business related to medicine and medical care. The company was founded on May 30, 1991 and is headquartered in Tokyo, Japan. | Health Technology |
EPS Global Research, Inc.
EPS Global Research, Inc. Miscellaneous Commercial ServicesCommercial Services Part of EPS Holdings, Inc., EPS Global Research, Inc. operates clinical trials. | Commercial Services |
- Bourse
- Insiders
- Kazuki Sekitani
- Expérience